首頁 > 市場調查報告書 > 醫療設備

e保健

市場調查報告書

商品編碼

1747016

日本數位治療市場報告（按應用（糖尿病、肥胖症、心血管疾病、中樞神經系統疾病、呼吸系統疾病、戒菸等）、最終用途（患者、提供者、付款人、雇主等）和地區）2025 年至 2033 年

Japan Digital Therapeutics Market Report by Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, and Others), End Use (Patients, Providers, Payers, Employers, and Others), and Region 2025-2033

出版日期: 2025年06月02日 | 出版商:

IMARC | 英文 121 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024年，日本數位治療市場規模達3.195億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到19.245億美元，2025-2033年期間的複合年成長率（CAGR）為20.43%。關節炎、心血管併發症、糖尿病和骨質疏鬆症等各種慢性疾病的盛行率不斷上升，人工智慧(AI)和機器學習(ML)的不斷進步，以及清晰的指導方針和框架的日益完善，是推動市場發展的一些關鍵因素。

數位療法是基於軟體的干涉措施，旨在透過改變患者行為和提供臨床支持來帶來積極的健康結果。它們包括行為療法應用程式，專注於改變行為模式以解決壓力、焦慮和憂鬱等心理健康問題。它們還包括慢性病管理平台，透過藥物提醒、活動追蹤和個人化健康建議等功能幫助患者監測和管理自身狀況。它們還包含遠端患者監測，即使用穿戴式裝置和感測器遠端監測患者的生命徵象和健康指標。它們依靠科學證據和臨床試驗來確保其有效性。它們通常經過嚴格的測試，以驗證其對特定健康結果的影響。它們透過提供個人化和互動式體驗來優先考慮用戶參與度。它們可能包含即時回饋、進度追蹤和方便用戶使用介面等功能。數位療法旨在補充傳統的醫療保健方法。它們可以與電子健康記錄 (EHR) 整合，並將患者與醫療保健提供者聯繫起來，以實現無縫的護理協調。它們對術後復健、慢性病管理和老年人護理非常有用。它們透過提供便利且經濟高效的解決方案來增加醫療保健的可近性。數位療法可以提供一種比傳統療法更經濟有效的替代方案。

日本數位治療市場趨勢：

目前，數位療法透過讓患者積極參與護理、持續監測和個人化干預來改善患者健康狀況，因此對其需求不斷成長，這是推動日本市場成長的關鍵因素之一。此外，關節炎、心血管併發症、糖尿病和骨質疏鬆症等各種慢性病的盛行率不斷上升，推動人們採用創新有效的治療方式。數位療法由於能夠提供個人化和遠距干預，解決了慢性病日益加重的負擔。此外，技術的不斷進步，特別是人工智慧 (AI) 和機器學習 (ML) 領域的技術進步，使數位介入能夠分析大量資料集、個人化治療計劃並不斷適應個別患者的需求。穿戴式裝置、感測器和其他連接裝置的整合進一步增強了數位療法收集即時健康資料的能力，為臨床醫生提供明智的決策依據。此外，日益轉向基於價值的護理模式以及對預防性醫療保健的重視，正在加速數位療法作為管理慢性病的經濟高效策略在該國的應用。監管機構、患者和醫療保健提供者也認知到投資數位干預措施的經濟效益，這些措施不僅可以治療慢性病，還可以預防其惡化。此外，關於數位療法核准及其融入主流醫療保健的明確指導方針和框架的持續建立，也正在支持該國市場的成長。

日本數位治療市場細分：

應用程式洞察：

糖尿病
肥胖
化學氣相沉積
中樞神經系統疾病
呼吸系統疾病
戒菸
其他

最終用途洞察：

患者
提供者
付款人
雇主
其他

競爭格局：

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀錶板和公司評估象限等競爭分析。此外，報告還提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本數位治療市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本數位治療市場有何影響？
日本數位治療市場根據應用如何分類？
根據最終用途，日本數位治療市場是如何分類的？
日本數位治療市場的價值鏈分為哪些階段？
日本數位療法的主要促進因素和挑戰是什麼？
日本數位治療市場的結構是怎麼樣的？主要參與者是誰？
日本數位治療市場的競爭程度如何？

本報告回答的關鍵問題：

日本數位治療市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本數位治療市場有何影響？
日本數位治療市場根據應用如何分類？
根據最終用途，日本數位治療市場是如何分類的？
日本數位治療市場的價值鏈分為哪些階段？
日本數位療法的主要促進因素和挑戰是什麼？
日本數位治療市場的結構是怎麼樣的？主要參與者是誰？
日本數位治療市場的競爭程度如何？

Japan digital therapeutics market size reached USD 319.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,924.5 Million by 2033, exhibiting a growth rate (CAGR) of 20.43% during 2025-2033. The growing prevalence of various chronic diseases like arthritis, cardiovascular complications, diabetes, and osteoporosis, rising advancements in artificial intelligence (AI) and machine learning (ML), and increasing establishment of clear guidelines and frameworks represent some of the key factors driving the market.

Digital therapeutics are software-based interventions designed to bring about positive health outcomes by modifying patient behavior and providing clinical support. They comprise behavioral therapy apps, which focus on modifying behavior patterns to address mental health conditions, such as stress, anxiety, and depression. They also include chronic disease management platforms, which help patients monitor and manage their conditions through features like medication reminders, activity tracking, and personalized health recommendations. They encompass remote patient monitoring, which involves the use of wearable devices and sensors to monitor the vital signs and health metrics of patients remotely. They rely on scientific evidence and clinical trials to ensure their effectiveness. They often undergo rigorous testing to validate their impact on specific health outcomes. They prioritize user engagement by providing personalized and interactive experiences. They may include features like real-time feedback, progress tracking, and user-friendly interfaces. Digital therapeutics are designed to complement traditional healthcare approaches. They can integrate with electronic health records (EHRs) and connect patients with healthcare providers for seamless coordination of care. They are useful for post-surgery recovery, chronic disease management, and eldercare. They increase access to healthcare by providing convenient and cost-effective solutions. Digital therapeutics can offer a cost-effective alternative to traditional treatments.

Japan Digital Therapeutics Market Trends:

At present, the increasing demand for digital therapeutics as they contribute to better health outcomes by actively involving patients in their care and continuously monitoring and personalized interventions represents one of the crucial factors impelling the growth of the market in Japan. Besides this, the rising prevalence of various chronic diseases like arthritis, cardiovascular complications, diabetes, and osteoporosis is driving the adoption of innovative and effective treatment modalities. Digital therapeutics addresses the increasing burden of chronic illnesses due to its ability to deliver personalized and remote interventions. In addition, the growing advancements in technology, particularly in the realms of artificial intelligence (AI) and machine learning (ML), are empowering digital interventions to analyze vast datasets, personalize treatment plans, and continuously adapt to individual patient needs. The integration of wearables, sensors, and other connected devices further enhances the capability of digital therapeutics to collect real-time health data, providing clinicians with valuable insights for informed decision-making. Apart from this, the increasing shift towards value-based care models and a focus on preventive healthcare is accelerating the adoption of digital therapeutics as a cost-efficient strategy for managing chronic conditions in the country. Regulatory bodies, patients, and healthcare providers are also recognizing the economic benefits of investing in digital interventions that not only treat but also prevent the exacerbation of chronic diseases. Additionally, the rising establishment of clear guidelines and frameworks for digital therapeutics approval and integration into mainstream healthcare is supporting the market growth in the country.

Japan Digital Therapeutics Market Segmentation:

Application Insights:

Diabetes
Obesity
CVD
CNS Disease
Respiratory Diseases
Smoking Cessation
Others

End Use Insights:

Patients
Providers
Payers
Employers
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan digital therapeutics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan digital therapeutics market?
What is the breakup of the Japan digital therapeutics market on the basis of application?
What is the breakup of the Japan digital therapeutics market on the basis of end use?
What are the various stages in the value chain of the Japan digital therapeutics market?
What are the key driving factors and challenges in the Japan digital therapeutics?
What is the structure of the Japan digital therapeutics market and who are the key players?
What is the degree of competition in the Japan digital therapeutics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Digital Therapeutics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Digital Therapeutics Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Digital Therapeutics Market - Breakup by Application

6.1 Diabetes
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Obesity
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 CVD
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
6.4 CNS Disease
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)
6.5 Respiratory Diseases
- 6.5.1 Overview
- 6.5.2 Historical and Current Market Trends (2019-2024)
- 6.5.3 Market Forecast (2025-2033)
6.6 Smoking Cessation
- 6.6.1 Overview
- 6.6.2 Historical and Current Market Trends (2019-2024)
- 6.6.3 Market Forecast (2025-2033)
6.7 Others
- 6.7.1 Historical and Current Market Trends (2019-2024)
- 6.7.2 Market Forecast (2025-2033)

7 Japan Digital Therapeutics Market - Breakup by End Use

7.1 Patients
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Providers
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Payers
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 Employers
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
7.5 Others
- 7.5.1 Historical and Current Market Trends (2019-2024)
- 7.5.2 Market Forecast (2025-2033)

8 Japan Digital Therapeutics Market - Competitive Landscape

8.1 Overview
8.2 Market Structure
8.3 Market Player Positioning
8.4 Top Winning Strategies
8.5 Competitive Dashboard
8.6 Company Evaluation Quadrant

9 Profiles of Key Players

9.1 Company A
- 9.1.1 Business Overview
- 9.1.2 Product Portfolio
- 9.1.3 Business Strategies
- 9.1.4 SWOT Analysis
- 9.1.5 Major News and Events
9.2 Company B
- 9.2.1 Business Overview
- 9.2.2 Product Portfolio
- 9.2.3 Business Strategies
- 9.2.4 SWOT Analysis
- 9.2.5 Major News and Events
9.3 Company C
- 9.3.1 Business Overview
- 9.3.2 Product Portfolio
- 9.3.3 Business Strategies
- 9.3.4 SWOT Analysis
- 9.3.5 Major News and Events
9.4 Company D
- 9.4.1 Business Overview
- 9.4.2 Product Portfolio
- 9.4.3 Business Strategies
- 9.4.4 SWOT Analysis
- 9.4.5 Major News and Events
9.5 Company E
- 9.5.1 Business Overview
- 9.5.2 Product Portfolio
- 9.5.3 Business Strategies
- 9.5.4 SWOT Analysis
- 9.5.5 Major News and Events

10 Japan Digital Therapeutics Market - Industry Analysis

10.1 Drivers, Restraints, and Opportunities
- 10.1.1 Overview
- 10.1.2 Drivers
- 10.1.3 Restraints
- 10.1.4 Opportunities
10.2 Porters Five Forces Analysis
- 10.2.1 Overview
- 10.2.2 Bargaining Power of Buyers
- 10.2.3 Bargaining Power of Suppliers
- 10.2.4 Degree of Competition
- 10.2.5 Threat of New Entrants
- 10.2.6 Threat of Substitutes
10.3 Value Chain Analysis